Career

Managing Director and Co-Founder
Co-founded and currently leads a venture investing firm focused on healthcare and life sciences, raising significant capital for innovative biotech solutions. The firm specializes in identifying and funding disruptive technologies in areas like gene editing and digital health.
Oversees the firm's investment strategy, which includes identifying and funding over a dozen companies in gene editing and other health technologies since 2014. He leverages his scientific background to guide investment decisions.

Chief Advisor for Science and Technology
Served as the principal scientific and technological advisor to Bill Gates, guiding strategic investments across various sectors, including global health and technology. This role involved leading select for-profit and philanthropic initiatives.

Assistant Professor / Postdoctoral Fellow
Conducted postdoctoral training and research at Harvard Medical School, focusing on complex areas such as immunogenetics and immunological tolerance. This research contributed to his deep expertise in the life sciences.
Education
M.D.
Completed medical training at the University of Zagreb, which provided a foundational understanding of clinical practice and human biology. This education is the basis for his later work in immunology and biotech investment.
Skills
Core technical, scientific, and professional competencies derived from his background in medicine, research, and venture capital.
Scientific & Medical Expertise
Immunology
Immunogenetics
Gene Editing
Biotechnology
Drug Discovery
Clinical Research
Investment & Business Skills
Venture Capital
Investment Strategy
Due Diligence
Portfolio Management
Business Development
Startup Incubation
Advisory & Leadership
Strategic Advising
Science Policy
Global Health Initiatives
Technology Scouting
Cross-Sector Collaboration
Domains
Primary
Biotechnology, Venture Capital, Global Health, Life Sciences
Secondary
Immunology, Gene Editing, Health Technology, Science Policy
Tags
Personality
Visionary, Strategic, Scientific, Results-Oriented, Global Perspective
Focus
Biotech Investment, Health Innovation, Philanthropic Strategy, Future of Medicine